Dr. Akshay Kant Chaturvedi

Executive Director, Shivalik Rasayan Limited.

Dr Akshay Kant Chaturvedi is known as hardcore Scientist and Inventor, there are over 200 publications/ Patents (Several Granted patents in US, Europe/AU/NZ/IN etc)/Journals /symposium globally.

After securing university gold medal in post-graduation in Medicinal Chemistry from Bareilly College, Bareilly, INDIA, he has started his career in 1992 from a chemical industry in Kolkata. Subsequently after a short term, he has got the opportunity to enter Ph.D. program on a Synthetic Medicinal Chemistry work. 

Presently, he is known to be an Organic Chemist and Formulation Scientist having over 28 years of hands on experience in R&D of APIs/Formulations/New Drug Delivery Systems/NCEs etc and their IP rights. A well-known scientist in the Oncology Product’s domain, IP drive focused specifically on Patents and Research & Development Activities inclusive of Formulations/Organic Synthesis/ Intermediates/Bulk Drugs/Biotech/Agro products etc.

He is having exposure of working in organizations like Jubilant Organosys Ltd./ Dabur Pharma (Presently known as Fresenius Kabi Oncology Ltd.)/Dr REDDYS LABS, Hyderbabad/ Shilpa Medicare Limited / Granules India Limited, Hyderabad and SHIVALIK RASAYAN LIMITED, Bhiwadi on wide spectrum of activities to drive and support the quick pace development through R&D. He has accolades of becoming Synergictic Bridge between APIs and Formulations R&D activities to vertically integrate economically viable products at best efficiency levels.

Recently, he was among the eminent speakers of CPHI Preconnect Congress 2022, Noida.

Presently, he is independently steering entire R&D Centre (Both API & Formulations) and supporting Business development Activities, besides IP driven strategic R&D activities of both APIs and Formulations for Contract Manufacturing of customers as well as in-house planned Paragraph IV ANDA products for US markets.